Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy
It is always recommended that you check with your health insurance provider to see if they can offer at least partial coverage for the treatments
Your provider will recommend the best option for you
They're not interchangeable, and the difference between CPT code 96372 and 90471 comes down to one question: is the drug a vaccine or a therapeutic agent
US$ 21.30
US$ 28.81
US$ 29.26
US$ 21.00
US$ 20.04
